Brainstorm Cell Debt
| BCLI Stock | USD 1.74 0.12 7.41% |
Brainstorm Cell Ther holds a debt-to-equity ratio of 0.604. The Brainstorm Cell's current Short Term Debt is estimated to increase to about 1.1 M, while Short and Long Term Debt Total is projected to decrease to under 638.4 K. With a high degree of financial leverage come high-interest payments, which usually reduce Brainstorm Cell's Earnings Per Share (EPS).
Asset vs Debt
Equity vs Debt
Brainstorm Cell's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Brainstorm Cell's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Brainstorm Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Brainstorm Cell's stakeholders.
For most companies, including Brainstorm Cell, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Brainstorm Cell Therapeutics, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Brainstorm Cell's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book 65.8173 | Book Value (1.21) | Return On Assets (1.78) | Return On Equity (11.22) |
Given that Brainstorm Cell's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Brainstorm Cell is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Brainstorm Cell to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Brainstorm Cell is said to be less leveraged. If creditors hold a majority of Brainstorm Cell's assets, the Company is said to be highly leveraged.
As of now, Brainstorm Cell's Non Current Liabilities Total is increasing as compared to previous years. The Brainstorm Cell's current Non Current Liabilities Other is estimated to increase to about 4.4 M, while Total Current Liabilities is projected to decrease to under 4.2 M. Brainstorm |
Brainstorm Cell Bond Ratings
Brainstorm Cell Therapeutics financial ratings play a critical role in determining how much Brainstorm Cell have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Brainstorm Cell's borrowing costs.| Piotroski F Score | 3 | Frail | View |
| Beneish M Score | (4.83) | Unlikely Manipulator | View |
Brainstorm Cell Ther Debt to Cash Allocation
As Brainstorm Cell Therapeutics follows its natural business cycle, the capital allocation decisions will not magically go away. Brainstorm Cell's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors.
Brainstorm Cell Therapeutics currently holds 672 K in liabilities with Debt to Equity (D/E) ratio of 0.6, which is about average as compared to similar companies. Brainstorm Cell Ther has a current ratio of 1.6, which is within standard range for the sector. Note, when we think about Brainstorm Cell's use of debt, we should always consider it together with its cash and equity.Brainstorm Cell Total Assets Over Time
Brainstorm Cell Assets Financed by Debt
The debt-to-assets ratio shows the degree to which Brainstorm Cell uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.Brainstorm Cell Debt Ratio | 17.0 |
Brainstorm Cell Corporate Bonds Issued
Most Brainstorm bonds can be classified according to their maturity, which is the date when Brainstorm Cell Therapeutics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Brainstorm Short Long Term Debt Total
Short Long Term Debt Total |
|
Understaning Brainstorm Cell Use of Financial Leverage
Understanding the composition and structure of Brainstorm Cell's debt gives an idea of how risky is the capital structure of the business and if it is worth investing in it. The degree of Brainstorm Cell's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets).
| Last Reported | Projected for Next Year | ||
| Short and Long Term Debt Total | 672 K | 638.4 K | |
| Net Debt | -628 K | -659.4 K | |
| Short Term Debt | 603 K | 1.1 M | |
| Net Debt To EBITDA | 0.04 | 0.04 | |
| Debt To Equity | (0.16) | (0.15) | |
| Interest Debt Per Share | 0.02 | 0.02 | |
| Debt To Assets | 0.18 | 0.17 | |
| Long Term Debt To Capitalization | (0.16) | (0.14) | |
| Total Debt To Capitalization | (0.18) | (0.19) | |
| Debt Equity Ratio | (0.16) | (0.15) | |
| Debt Ratio | 0.18 | 0.17 | |
| Cash Flow To Debt Ratio | (35.01) | (33.26) |
Currently Active Assets on Macroaxis
When determining whether Brainstorm Cell Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainstorm Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainstorm Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainstorm Cell Therapeutics Stock:Check out the analysis of Brainstorm Cell Fundamentals Over Time. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brainstorm Cell. If investors know Brainstorm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.45) | Return On Assets (1.78) | Return On Equity (11.22) |
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brainstorm Cell's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brainstorm Cell is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainstorm Cell's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.